Inspire Medical Systems Inc has nabbed $37.5 million in venture funding as it ramps up sales of its implantable device for treating sleep apnea, reports Minneapolis/St. Paul Business Journal.
For now, individual patients can turn to an authorization-and-appeals process to seek insurance coverage for the Inspire procedure. Many patients have succeeded, but Inspire wants insurers to have broader policies in place to cover the product, Herbert said. That hasn’t happened yet partly because Inspire’s device is novel and insurers want to see more data, Herbert said.
“Insurance companies are still getting use to it,” Herbert said. “The good news is they are paying for it.”